A lot of factors are keeping M&A activity alive in home health and hospice – from baby boomers reaching Medicare age, to continuum of care to improve patient outcomes and reducing costs. Home Health and Hospice Managing Director Mark Kulik recently spoke to Home Health Care News discussing the continued interest in the sector after the recently announced stock buyback announcement from Amedisys.
“These recent times have been the greatest valuation period for home health and hospice that we have on record. There are several strong tailwinds fueling it, including the baby boomers coming of age. We’re finally getting to the point where the [health care] industry at large is recognizing that home health and hospice really are part of the solution. If you truly want to reign in the runaway cost of health care, and you truly want to see significant advancements in positive outcomes, then home health and hospice, absolutely, are major parts of that formula.”
– Mark Kulik